Damora Therapeutics Announces CFO Transition; Appoints Internal SVP Finance as Successor

summarizeSummary

Damora Therapeutics announced the departure of its CFO, Lori Firmani, and the appointment of Brian Burkavage, its Senior Vice President of Finance, as the new principal financial and accounting officer, effective May 1, 2026.

check_boxKey Events

• CFO Departs

  Lori Firmani ceased serving as Chief Financial Officer, principal financial officer, and principal accounting officer, effective May 1, 2026.

• Separation Benefits Granted

  Ms. Firmani will receive separation benefits, including a lump sum for base salary continuation, a pro-rated target bonus, a $6,000 HSA contribution, and full acceleration of all outstanding equity awards, as outlined in the company's Executive Separation Benefits Plan.

• New Principal Financial Officer Appointed

  Brian Burkavage, the company's Senior Vice President, Finance, has been appointed to serve as the new principal financial officer and principal accounting officer, effective May 1, 2026.

• Successor's Extensive Experience

  Mr. Burkavage brings significant experience, having previously served as SVP, Finance and Chief Accounting Officer at IO Biotech, Inc., Controller at Passage Bio, Inc., and Director of Financial Planning and Analysis at Aclaris Therapeutics, Inc., in addition to 11 years at Ernst & Young LLP.

auto_awesomeAnalysis

Damora Therapeutics announced a change in its financial leadership, with Lori Firmani ceasing her role as CFO and Brian Burkavage, the current Senior Vice President of Finance, stepping in as the new principal financial and accounting officer. While a CFO departure can introduce uncertainty, the appointment of an experienced internal candidate like Mr. Burkavage, who has a strong background in biotech finance and accounting, provides continuity. The full acceleration of equity awards for the departing CFO is a notable separation benefit. This transition occurs as the company is undergoing a major strategic pivot and has recently secured significant capital, making stable financial leadership crucial.